| HOME >> MEDICINE >> TECHNOLOGY |
Table 98: Betagenon's Included Breast Cancer Drugs and Competitive Fall-Out 1008
Table 99: Biogen Idec's Included Breast Cancer Drugs and Competitive Fall-Out 1011
Table 100: BioMarin's Included Breast Cancer Drugs and Competitive Fall-Out 1014
Table 101: Bionovo's Included Breast Cancer Drugs and Competitive Fall-Out 1017
Table 102: BioSante's Included Breast Cancer Drugs and Competitive Fall-Out 1020
Table 103: Biotecnol's Included Breast Cancer Drugs and Competitive Fall-Out 1024
Table 104: Boehringer Ingelheim's Included Breast Cancer Drugs and Competitive Fall-Out 1027
Table 105: Bristol-Myers Squibb's Included Breast Cancer Drugs and Competitive Fall-Out 1033
Table 106: BTG's Included Breast Cancer Drugs and Competitive Fall-Out 1042
Table 107: Callisto Pharmaceuticals' Included Breast Cancer Drugs and Competitive Fall-Out 1047
Table 108: Cancer Research Technology's Included Breast Cancer Drugs and Competitive Fall-Out 1050
Table 109: Cel-Sci's Included Breast Cancer Drugs and Competitive Fall-Out 1053
Table 110: Celgene's Included Breast Cancer Drugs and Competitive Fall-Out 1057
Table 111: Cell Therapeutics' Included Breast Cancer Drugs and Competitive Fall-Out 1063
Table 112: Celldex Therapeutics' Included Breast Cancer Drugs and Competitive Fall-Out 1066
Table 113: Celltrion's Included Breast Cancer Drugs and Competitive Fall-Out 1070
Table 114: Celsion's Included Breast Cancer Drugs and Competitive Fall-Out 1074
Table 115: Celtic Pharma's Included Breast Cancer Drugs and Competitive Fall-Out 1076
Table 116: Center of Molecular Immunology's Included Breast Cancer Drugs and Competitive Fall-Out 1079
Table 117: Chemokine Therapeutics' Included Breast Cancer Drugs and Competitive Fall-Out 1082
Table 118: Chiesi's Included Breast Cancer Drugs
'/>"/>
| SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved |